Overview
- Product nameAnti-Smad2 antibodySee all Smad2 primary antibodies ...
- DescriptionRabbit polyclonal to Smad2
- Tested applicationsIHC-Fr, WB, IHC-P, ICC/IF, ELISA more details
- Species reactivityReacts with: Mouse, Rat, Human
- Immunogen
Synthetic non-phosphopeptide derived from human Smad2 around the phosphorylation site of serine 467 (C-S-S-M-S).
- Positive controlHepG2 cells. Prostate carcinoma.
Properties
- FormLiquid
- Storage instructionsStore at -20°C. Stable for 12 months at -20°C
- Storage bufferPreservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS, 150mM Sodium chloride, pH 7.4 -
Concentration information loading... - PurityImmunogen affinity purified
- Clonality Polyclonal
- IsotypeIgG
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab63576 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| IHC-Fr | IHC-Fr: Use at an assay dependent concentration. |
| WB | WB: 1/300 - 1/1000. Detects a band of approximately 58 kDa (predicted molecular weight: 58 kDa). |
| IHC-P | IHC-P: 1/50 - 1/100. |
| ICC/IF | ICC/IF: 1/500 - 1/1000. |
| ELISA | ELISA: 1/5000. |
Target
- FunctionReceptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma.
- Tissue specificityExpressed at high levels in skeletal muscle, heart and placenta.
- Sequence similaritiesBelongs to the dwarfin/SMAD family.
Contains 1 MH1 (MAD homology 1) domain.
Contains 1 MH2 (MAD homology 2) domain. - Post-translational
modificationsPhosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases. Able to interact with SMURF2 when phosphorylated on Ser-465/467, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, phosphorylated on Ser-240 by CaMK2. Phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin.
In response to TGF-beta, ubiquitinated by NEDD4L; which promotes its degradation.
Acetylated on Lys-19 by coactivators in response to TGF-beta signaling, which increases transcriptional activity. Isoform short: Acetylation increases DNA binding activity in vitro and enhances its association with target promoters in vivo. Acetylation in the nucleus by EP300 is enhanced by TGF-beta. - Cellular localizationCytoplasm. Nucleus. Cytoplasmic and nuclear in the absence of TGF-beta. On TGF-beta stimulation, migrates to the nucleus when complexed with SMAD4. On dephosphorylation by phosphatase PPM1A, released from the SMAD2/SMAD4 complex, and exported out of the nucleus by interaction with RANBP1.
-
Database links
- Entrez Gene: 4087 Human
- Entrez Gene: 17126 Mouse
- Entrez Gene: 29357 Rat
- Omim: 601366 Human
- SwissProt: Q15796 Human
- SwissProt: Q62432 Mouse
- SwissProt: O70436 Rat
- Unigene: 12253 Human
- Unigene: 705764 Human
- Unigene: 391091 Mouse
- Unigene: 2755 Rat
see all
Target information above from: UniProt accession
Q15796
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
-
Alternative names
- hMAD 2 antibodyhMAD-2 antibodyhSMAD2 antibody
- JV18 1 antibodyJV18 antibodyJV18-1 antibodyJV181 antibodyMAD antibodyMAD homolog 2 antibodyMAD Related Protein 2 antibodyMad-related protein 2 antibodyMADH2 antibodyMADR2 antibodyMGC22139 antibodyMGC34440 antibodyMothers Against Decapentaplegic Homolog 2 antibodymothers against DPP homolog 2 antibodyOTTHUMP00000163489 antibodySma and Mad related protein 2 antibodySMAD 2 antibodySMAD antibodySMAD family member 2 antibodySMAD, mothers against DPP homolog 2 antibodySMAD2 antibodySMAD2_HUMAN antibody
see all
Anti-Smad2 antibody images
-
ab63576, at a 1/50 dilution, staining human Smad2 in prostate carcinoma, using Immunohistochemistry, Formalin/PFA fixed Paraffin embedded tissue, minus immunising peptide (left image) and plus immunising peptide (right image).
-
Immunofluorescent staining of HepG2 cells, using ab63576 at a 1/500 dilution, minus immunising peptide (left image) and plus immunising peptide (right image).
-
Immunocytochemistry/ Immunofluorescence - Smad2 antibody (ab63576)This image is courtesy of an anonymous Abreviewab63576 staining Smad2 in Mouse enterocytes by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with 0.5% Triton and blocked with 5% BSA for 1 hour at 20°C. Samples were incubated with primary antibody (1/250) for 2 hours at 20°C. An Alexa Fluor®488-conjugated Goat anti-rabbit IgG polyclonal (1/1000) was used as the secondary antibody. -
Anti-Smad2 antibody (ab63576) at 1/1000 dilution (for 17 hours at 4°C) + Mouse brain whole cell lysate at 18 µg
Secondary
An HRP-conjugated Goat anti-rabbit IgG polyclonal at 1/10000 dilution
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 58 kDa
Observed band size : 58 kDa
Exposure time : 2 minutesThis image is courtesy of an anonymous Abreview
-
Anti-Smad2 antibody (ab63576) at 1/1000 dilution (for 16 hours at 4°C) + Rat intestine whole cell lysate at 25 µg
Secondary
An HRP-conjugated Goat anti-rabbit IgG at 1/10000 dilution
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 58 kDa
Observed band size : 58 kDa
Exposure time : 140 secondsThis image is courtesy of an anonymous Abreview
References for Anti-Smad2 antibody (ab63576)
This product has been referenced in:
- Spiller CM et al. Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development 139:4123-32 (2012). IHC-P ; Mouse . Read more (PubMed: 23034635) »



